Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) was the target of a significant growth in short interest in May. As of May 15th, there was short interest totaling 75,000 shares, a growth of 3,650.0% from the April 30th total of 2,000 shares. Based on an average daily trading volume, of 909 shares, the days-to-cover ratio is currently 82.5 days.
Viva Biotech Price Performance
Shares of OTCMKTS VBIZF opened at $0.20 on Friday. The business’s 50 day moving average price is $0.30 and its two-hundred day moving average price is $0.29. Viva Biotech has a twelve month low of $0.20 and a twelve month high of $0.20.
Viva Biotech Company Profile
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Featured Stories
- Five stocks we like better than Viva Biotech
- Marvell’s Pullback May Be the Setup Bulls Were Waiting For
- Flight Path to Profits: American Airlines Bets on SpaceX
- Wall Street Is Starting to Talk About Tesla’s Endgame
- Meta’s Manus Mess: Why China Blocked the Deal and What It Means
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
